Randomized Phase
            II
            Study of
            First‐Line
            Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated
            Non‐Small
            Cell Lung Cancer:
            LOGIK0801

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30568-8 ◽

2015 ◽

Vol 51 ◽

pp. S196

Author(s):

M. Tamiya ◽

A. Tamiya ◽

H. Kaneda ◽

K. Nakagawa ◽

K. Goto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Journal of Translational Medicine ◽

10.1186/1479-5876-6-65 ◽

2008 ◽

Vol 6 (1) ◽

Cited By ~ 1

Author(s):

Alessandro Passardi ◽

Lorenzo Cecconetto ◽

Monia Dall'Agata ◽

Claudio Dazzi ◽

Enzo Pasquini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Randomized Phase Ii ◽

Weekly Regimen of Paclitaxel and Carboplatin as First-Line Chemotherapy in Elderly Patients with Stage IIIB-IV Non Small Cell Lung Cancer (NSCLC): Results of a Phase II Study

Journal of Chemotherapy ◽

10.1179/joc.2010.22.6.419 ◽

2010 ◽

Vol 22 (6) ◽

pp. 419-423 ◽

Cited By ~ 9

Author(s):

A. Rozzi ◽

C. Nardoni ◽

M. Corona ◽

M.R. Restuccia ◽

T. Falbo ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Faculty Opinions recommendation of Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase-II study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952712.793458182 ◽

2012 ◽

Author(s):

Bruno Andreoni ◽

Gianmarco Contino

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

A phase II study of pemetrexed and gemcitabine plus bevacizumab as first-line chemotherapy for elderly patients with stage IIIb/IV non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18023 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18023-e18023

Author(s):

L. Blakely ◽

L. S. Schwartzberg ◽

F. M. Schnell ◽

K. D. Sabbath ◽

P. J. Miller ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line chemotherapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7628 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7628-7628 ◽

Cited By ~ 1

Author(s):

S. Nagel ◽

A. Groeschel ◽

M. Sebastian ◽

S. Andreas ◽

T. Mueller ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Randomized Phase Ii ◽

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mdq630 ◽

2011 ◽

Vol 22 (7) ◽

pp. 1528-1534 ◽

Cited By ~ 39

Author(s):

C. Gridelli ◽

F. Morgillo ◽

A. Favaretto ◽

F. de Marinis ◽

A. Chella ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: A randomized, phase-II study

Lung Cancer ◽

10.1016/j.lungcan.2012.05.106 ◽

2012 ◽

Vol 77 (3) ◽

pp. 550-555 ◽

Cited By ~ 7

Author(s):

Hideki Kusagaya ◽

Naoki Inui ◽

Masato Karayama ◽

Yutaro Nakamura ◽

Shigeki Kuroishi ◽

...

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule

Lung Cancer ◽

10.1016/j.lungcan.2004.08.012 ◽

2005 ◽

Vol 47 (3) ◽

pp. 405-412 ◽

Cited By ~ 18

Author(s):

Elisabeth Quoix ◽

Jean-Luc Breton ◽

Alain Ducoloné ◽

Bertrand Mennecier ◽

Alain Depierre ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Randomized Phase Ii ◽

A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer

Medical Oncology ◽

10.1007/s12032-015-0715-7 ◽

2015 ◽

Vol 33 (1) ◽

Cited By ~ 15

Author(s):

Motohiro Tamiya ◽

Akihiro Tamiya ◽

Hiroyasu Kaneda ◽

Kazuhiko Nakagawa ◽

Kiyotaka Yoh ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽